2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Quality of Life: Addressing the long-term physical, psychological, and social effects of cancer.
Quality of life (QoL) is a critical concern in cancer research, as the impact of cancer extends beyond physical health to affect a patient’s psychological and social well-being. Survivors may experience long-term effects such as fatigue, pain, and cognitive impairments, as well as emotional distress, depression, and anxiety. Addressing these aspects of QoL is essential for ensuring that cancer treatments not only focus on survival but also on the patient’s overall well-being. Research in this area explores interventions like psychological counseling, support groups, and physical rehabilitation, aiming to improve mental health, alleviate symptoms, and help patients reintegrate into daily life. Furthermore, social support systems play a pivotal role in enhancing QoL by providing emotional and practical assistance. By focusing on the multifaceted effects of cancer, researchers and healthcare providers can develop holistic treatment plans that improve the long-term quality of life for patients and survivors alike.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China